Published in PLoS One on September 13, 2010
Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume | NCT04885153
Animal models of diabetic retinopathy: summary and comparison. J Diabetes Res (2013) 1.09
Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol (2011) 1.00
Role of the retinal vascular endothelial cell in ocular disease. Prog Retin Eye Res (2012) 0.99
Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy (2011) 0.98
Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia (2013) 0.98
Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis. Mediators Inflamm (2014) 0.97
Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin. Int J Endocrinol Metab (2014) 0.95
Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions. Mol Vis (2013) 0.91
Novel drugs and their targets in the potential treatment of diabetic retinopathy. Med Sci Monit (2013) 0.90
Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway. Invest Ophthalmol Vis Sci (2013) 0.85
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice. PLoS One (2013) 0.84
The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells. PLoS One (2015) 0.83
Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice. PLoS One (2015) 0.82
2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.81
Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes. Mediators Inflamm (2015) 0.81
miR-15a/16 reduces retinal leukostasis through decreased pro-inflammatory signaling. J Neuroinflammation (2016) 0.81
Potential role of polyunsaturated fatty acids in diabetic retinopathy. Arch Med Sci (2014) 0.80
The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. Am J Physiol Heart Circ Physiol (2013) 0.79
Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease. Hematology (2014) 0.79
Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice. J Diabetes Res (2015) 0.79
Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ mice. Exp Diabetes Res (2012) 0.78
Bilberries potentially alleviate stress-related retinal gene expression induced by a high-fat diet in mice. Mol Vis (2012) 0.78
Diabetes alters intracellular calcium transients in cardiac endothelial cells. PLoS One (2012) 0.77
NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis. Sci Rep (2015) 0.76
Epigenetic Regulation of Redox Signaling in Diabetic Retinopathy: Role of Nrf2. Free Radic Biol Med (2016) 0.75
Interdependencies among Selected Pro-Inflammatory Markers of Endothelial Dysfunction, C-Peptide, Anti-Inflammatory Interleukin-10 and Glucose Metabolism Disturbance in Obese Women. Int J Med Sci (2016) 0.75
Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation. Mediators Inflamm (2017) 0.75
Detrimental impact of hyperlipidemia on the peripheral nervous system: A novel target of medical epidemiological and fundamental research study. Neural Regen Res (2012) 0.75
Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions. Arch Med Sci (2016) 0.75
Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation. Sci Rep (2016) 0.75
The impact of Roux-en-Y gastric bypass surgery on normal metabolism in a porcine model. PLoS One (2017) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Inflammation in atherosclerosis. Nature (2002) 28.92
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques (1993) 9.61
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82
Diabetic retinopathy. Lancet (2010) 5.38
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res (2007) 3.67
Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest (1985) 3.49
NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest (2001) 3.34
Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes (2006) 3.31
Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab (2009) 2.95
Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med (2007) 2.72
Recipes for creating animal models of diabetic cardiovascular disease. Circ Res (2007) 2.34
Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes (1997) 2.33
Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol (2008) 2.26
Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina (2008) 2.20
TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis (2009) 2.08
Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) (2009) 2.06
Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One (2009) 2.00
The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res (2007) 2.00
Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm (Vienna) (2006) 1.96
Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci (2004) 1.89
Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int Immunol (1996) 1.83
Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes (2007) 1.77
IL-2 and IFN-gamma in the retina of diabetic rats. Graefes Arch Clin Exp Ophthalmol (2010) 1.56
The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci (2005) 1.55
Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest Ophthalmol Vis Sci (2006) 1.35
Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care (2009) 1.25
The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabetes Res Clin Pract (2005) 1.23
Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes (2002) 1.22
Diabetic atherosclerosis mouse models. Atherosclerosis (2006) 1.17
The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol (2009) 1.17
Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation (1994) 1.12
TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. J Diabetes Complications (2008) 1.12
Soluble ICAM-1 and VCAM-1 as markers of endothelial activation. Scand J Immunol (2008) 1.11
Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models. Cytokine Growth Factor Rev (2008) 1.09
Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients. J Diabetes Complications (2006) 1.09
Tumor necrosis factor (TNF) biology and cell death. Front Biosci (2008) 1.07
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabet Med (2007) 1.06
Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo. PLoS One (2010) 1.06
Endothelial signaling by Ig-like cell adhesion molecules. Arterioscler Thromb Vasc Biol (2007) 1.05
Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabet Med (2002) 1.05
Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp Diabetes Res (2007) 1.02
Targeting TNF-alpha receptors for neurotherapeutics. Trends Neurosci (2008) 0.97
Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion. Retina (2008) 0.97
Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2008) 0.96
Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci (1999) 0.94
Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) (2006) 0.93
Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy. Clin Exp Med (2008) 0.88
Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. J Mol Histol (2007) 0.88
Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality? Eye (Lond) (2009) 0.86
Neutrophils plug capillaries in acute experimental retinal ischemia. Microvasc Res (1994) 0.86
Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res (1999) 0.82
Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice. Arterioscler Thromb Vasc Biol (2009) 0.81
Expression of antioxidant enzymes in rat retinal ischemia followed by reperfusion. Metabolism (2006) 0.81
Modifying a standard method allows simultaneous extraction of RNA and protein, enabling detection of enzymes in the rat retina with low expressions and protein levels. Metabolism (2006) 0.81
Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol (2004) 2.41
Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology (2008) 2.09
[Reply on new drugs against type 2 diabetes: important to gain experience and knowledge]. Lakartidningen (2008) 2.03
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice. J Am Coll Cardiol (2007) 1.77
Expressed sequence tag-linked microsatellites as a source of gene-associated polymorphisms for detecting signatures of divergent selection in atlantic salmon (Salmo salar L.). Mol Biol Evol (2005) 1.77
Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol (2002) 1.59
Gastric bypass improves β-cell function and increases β-cell mass in a porcine model. Diabetes (2014) 1.57
Short communication: Dating components of human atherosclerotic plaques. Circ Res (2010) 1.54
HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 1.48
Plasticity of TRPC expression in arterial smooth muscle: correlation with store-operated Ca2+ entry. Am J Physiol Cell Physiol (2004) 1.43
NFAT regulates the expression of AIF-1 and IRT-1: yin and yang splice variants of neointima formation and atherosclerosis. Cardiovasc Res (2011) 1.42
Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet (2012) 1.40
Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing store-operated Ca2+ entry dependent on TRPC1. Circ Res (2003) 1.38
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.31
Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol (2006) 1.29
Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism (2004) 1.26
Exposure to p,p'-DDE: a risk factor for type 2 diabetes. PLoS One (2009) 1.22
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation (2004) 1.19
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol (2003) 1.19
Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. J Mol Cell Cardiol (2012) 1.18
Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Arterioscler Thromb Vasc Biol (2012) 1.17
Automated detection of fundus photographic red lesions in diabetic retinopathy. Invest Ophthalmol Vis Sci (2003) 1.16
Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med (2012) 1.16
Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2008) 1.15
TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. J Diabetes Complications (2008) 1.12
NFATc3 regulates trypsinogen activation, neutrophil recruitment, and tissue damage in acute pancreatitis in mice. Gastroenterology (2012) 1.11
Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol (2009) 1.08
NFAT regulation in smooth muscle. Trends Cardiovasc Med (2003) 1.08
Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes (2011) 1.08
Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 1.08
Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol (2012) 1.07
Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2012) 1.06
Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Metabolism (2006) 1.04
Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence. Atherosclerosis (2012) 1.03
High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol (2006) 1.03
CRP--marker or maker of cardiovascular disease? Arterioscler Thromb Vasc Biol (2005) 1.02
Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2005) 1.02
T cell modulation of intimal thickening after vascular injury: the bimodal role of IFN-gamma in immune deficiency. Arterioscler Thromb Vasc Biol (2005) 1.00
FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice. J Immunol (2010) 1.00
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice. BMC Immunol (2010) 1.00
Melatonin restores impaired contractility in aged guinea pig urinary bladder. J Pineal Res (2008) 0.99
Nuclear factor of activated T-cells transcription factors in the vasculature: the good guys or the bad guys? Curr Opin Lipidol (2008) 0.99
T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol (2013) 0.98
The importance of fibroblasts in remodelling of the human uterine cervix during pregnancy and parturition. Mol Hum Reprod (2007) 0.98
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. Eur Heart J (2008) 0.98
Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin Immunopathol (2009) 0.97
Characterization of the lipid droplet proteome of a clonal insulin-producing β-cell line (INS-1 832/13). J Proteome Res (2012) 0.97
Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion. Retina (2008) 0.97
Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells. Hum Mol Genet (2009) 0.97
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression. Autoimmunity (2005) 0.97
Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun (2008) 0.96
Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One (2008) 0.95
High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighbourhood--a population based study. BMC Public Health (2011) 0.94
Perilipin and adipophilin expression in lipid loaded macrophages. Biochem Biophys Res Commun (2007) 0.94
A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden). Cancer Causes Control (2003) 0.94
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events. Atherosclerosis (2007) 0.94
Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the Women's Health in the Lund Area study. Metabolism (2007) 0.94
Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol (2008) 0.94
Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke (2003) 0.93
Development of a diet quality index assessing adherence to the Swedish nutrition recommendations and dietary guidelines in the Malmö Diet and Cancer cohort. Public Health Nutr (2011) 0.93
The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling. Cardiovasc Res (2011) 0.92
Link between GIP and osteopontin in adipose tissue and insulin resistance. Diabetes (2013) 0.92
Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem (2001) 0.91
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease. Stroke (2007) 0.91
Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy. Acta Ophthalmol (2012) 0.91
Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages. Lipids Health Dis (2006) 0.91
Lymphocytes in atherosclerosis. Clin Chim Acta (2012) 0.90
Novel PPARgamma agonists GI 262570, GW 7845, GW 1929, and pioglitazone decrease calcium channel function and myogenic tone in rat mesenteric arteries. Pharmacology (2004) 0.90
The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The women's health in the Lund area study. Metabolism (2002) 0.90
Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. Eur Heart J (2004) 0.90
A high diet quality is associated with lower incidence of cardiovascular events in the Malmö diet and cancer cohort. PLoS One (2013) 0.89
B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10. Thromb Haemost (2015) 0.89
Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals. Arterioscler Thromb Vasc Biol (2013) 0.89
High disaccharide intake associates with atherogenic lipoprotein profile. Br J Nutr (2011) 0.89
Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. J Diabetes Complications (2002) 0.89
Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation (2011) 0.88
Effect of melatonin on age associated changes in Guinea pig bladder function. J Urol (2007) 0.88
Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects. Int J Biochem Cell Biol (2009) 0.88
Alternate trains of postural muscle vibration promote cyclic body displacement in standing parkinsonian patients. Mov Disord (2008) 0.87
Do sex hormones influence features of the metabolic syndrome in middle-aged women? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study. Fertil Steril (2007) 0.87
Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. Circ Res (2009) 0.87
Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. Atherosclerosis (2006) 0.87
Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. Endocrinology (2003) 0.87
HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later. PLoS One (2011) 0.87